Lexeo Therapeutics, Inc. (LXEO)
(Delayed Data from NSDQ)
$11.43 USD
+0.38 (3.44%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $11.42 -0.01 (-0.09%) 5:42 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 41% (102 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.14 | 1.59 | 9.99 |
Current Quarter Estimate | -0.64 | -1.21 | 61.00 |
Year Ago Quarter Estimate | -12.36 | -0.07 | 54.84 |
Next Quarter Estimate | -0.65 | -1.90 | 63.00 |
Next Year Estimate | -2.63 | 12.55 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 77.90 | 20.00 | 15.67 |
Next Year | 4.01 | 15.20 | 11.34 |
Last 5 Years | NA | 7.00 | 8.10 |
Next 5 Years | NA | 22.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -3.96 |
Price/Book (MRQ) | 2.21 | 1.61 |
Price/Cash Flow (MRFY) | NA | 9.71 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -58.89% |
Return on Equity (TTM) | -103.43% | -58.99% |
Debt to Equity (MRQ) | 0.01 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.